Antiphospholipid antibodies and the brain: A consensus report

R. L. Brey, E. Muscal, J. Chapman

Research output: Contribution to journalArticlepeer-review

33 Scopus citations


This report discusses the difference between antiphospholipid antibodies (aPL) as a predictor for first and recurrent ischemic stroke, whether or not concomitant systemic lupus erythematosus (SLE) increases aPL-associated risk, and the association of aPL with other neurological manifestations. The neurological manifestations covered in this report were selected because they are among the most common, including cognitive dysfunction, headache, multiple sclerosis and seizures/epilepsy. Recommendations are made regarding further research that is needed to clarify remaining uncertainties.

Original languageEnglish (US)
Pages (from-to)153-157
Number of pages5
Issue number2
StatePublished - Feb 1 2011


  • antiphospholipid syndrome
  • stroke
  • thrombosis

ASJC Scopus subject areas

  • Rheumatology


Dive into the research topics of 'Antiphospholipid antibodies and the brain: A consensus report'. Together they form a unique fingerprint.

Cite this